Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®

NCT00355121 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

882

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Meningitis
Tetanus
Diphtheria
Pertussis
Poliomyelitis

Interventions

BIOLOGICAL: Polysaccharide Diphtheria Toxoid Conjugate Vaccine
BIOLOGICAL: Polysaccharide Diphtheria Toxoid Conjugate Vaccine
BIOLOGICAL: Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Sponsor

Sanofi